iBio (IBIO) said Wednesday it received approval to transfer its stock listing to Nasdaq, with trading set to begin on March 4 under the same ticker symbol.
The stock will remain on the NYSE American until market close on March 3, according to the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.